Soleus Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.7M Buy
1,970,864
+648,500
+49% +$20.1M 2.82% 9
2025
Q4
$37M Buy
+1,322,364
New +$39.6M 1.36% 20
2023
Q4
Sell
-54,400
Closed -$1.52M 75
2023
Q3
$1.52M Sell
54,400
-140,000
-72% -$4.1M 0.14% 74
2023
Q2
$6.08M Sell
194,400
-35,600
-15% -$1.08M 0.68% 43
2023
Q1
$6.48M Buy
+230,000
New +$6.27M 0.67% 43

Other funds holding ALKS

Soleus Capital Management's ALKS Position: Q1 2026 in Review

Soleus Capital Management increased its Alkermes (ALKS) stake by 49% in Q1 2026, buying an estimated $20.1M and bringing the position to 1,970,864 shares worth $69.7M. The position accounts for 2.82% of the portfolio, ranked #9.

Soleus Capital Management first reported a position in ALKS in Q1 2023 and has held it in 5 quarters since. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Soleus Capital Management held 1,970,864 shares of Alkermes worth $69.7M as of Q1 2026.
  • Soleus Capital Management bought 648,500 Alkermes shares in Q1 2026, an estimated $20.1M.
  • Alkermes made up 2.82% of Soleus Capital Management's portfolio in Q1 2026, its #9 holding.
  • Soleus Capital Management first reported a position in Alkermes in Q1 2023 and has held it in 5 quarters since.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.